MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Incompatible

Epilim 100mg crushable tablets (Sanofi)

Explore other Sodium valproate formulations Explore other Sodium valproate 100mg tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim 200 gastro-resistant tablets (Sanofi)

Explore other Sodium valproate formulations Explore other Sodium valproate 200mg gastro-resistant tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim 500 gastro-resistant tablets (Sanofi)

Explore other Sodium valproate formulations Explore other Sodium valproate 500mg gastro-resistant tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 200 tablets (CST Pharma Ltd)

Explore other Sodium valproate formulations Explore other Sodium valproate 200mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 200 tablets (Sanofi)

Explore other Sodium valproate formulations Explore other Sodium valproate 200mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 200 tablets (Sigma Pharmaceuticals Plc)

Explore other Sodium valproate formulations Explore other Sodium valproate 200mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 300 tablets (CST Pharma Ltd)

Explore other Sodium valproate formulations Explore other Sodium valproate 300mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 300 tablets (Sanofi)

Explore other Sodium valproate formulations Explore other Sodium valproate 300mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 300 tablets (Sigma Pharmaceuticals Plc)

Explore other Sodium valproate formulations Explore other Sodium valproate 300mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 500 tablets (CST Pharma Ltd)

Explore other Sodium valproate formulations Explore other Sodium valproate 500mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 500 tablets (Sanofi)

Explore other Sodium valproate formulations Explore other Sodium valproate 500mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Epilim Chrono 500 tablets (Sigma Pharmaceuticals Plc)

Explore other Sodium valproate formulations Explore other Sodium valproate 500mg modified-release tablets suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Episenta 150mg modified-release capsules (Desitin Pharma Ltd)

Explore other Sodium valproate formulations Explore other Sodium valproate 150mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Episenta 300mg modified-release capsules (Desitin Pharma Ltd)

Explore other Sodium valproate formulations Explore other Sodium valproate 300mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Incompatible

Episenta 300mg modified-release capsules (Necessity Supplies Ltd)

Explore other Sodium valproate formulations Explore other Sodium valproate 300mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA as preparations are hygroscopic, which can affect release profile.

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.